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Chronic Exercise
A Contributing Factor to
Atrial Fibrillation?*
Xander H. T. Wehrens, MD, PHD,
David Y. Chiang, BS, Na Li, PHD
Houston, TexasAtrial ﬁbrillation (AF) is the most common cardiac
arrhythmia encountered in the clinical setting (1). In the
general population, the prevalence of AF increases with age,
ranging from 0.5% in patients younger than 40 years to 5%
in patients older than 65 years (2). Less is known about the
prevalence in athletes, with several epidemiological studies
reporting different ﬁndings due to variations in age, years of
training, and associated comorbidities. What is known,
however, is that athletes are prone to arrhythmias, and AF
is the most common arrhythmia in the athletic population.
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A number of studies have described that vigorous endurance
exercise, such as marathon running (3), cross-country skiing
(4), and cycling (5), increases the risk of AF in humans.
There are only a limited number of studies to date that have
investigated the epidemiology of AF in athletes. Moreover,
the mechanisms underlying AF development in athletes are
not well deﬁned.
A number of studies have shed light on possible causes of
AF in athletes such as structural remodeling, autonomic
nervous system alterations, hypovolemia, and illicit drug use,
as reviewed previously (2). Because of their endurance
training, athletes may experience a chronic increase in atrial
pressure. Elevated atrial pressure by itself can lead to atrial
dilation, shortening of the atrial effective refractory period,
and increased AF inducibility in the isolated Langendorff
perfused rabbit hearts (6). Conversely, one clinical study
found that while the left atrium was enlarged in a population*Editorials published in the Journal of the American College of Cardiology reﬂect the
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tachyarrhythmias was not increased (7). Besides enlarge-
ment, chronic inﬂammation leading to atrial ﬁbrosis has also
been proposed as a cause of AF in athletes (8,9). This
concept is supported by the observation of acute elevated
inﬂammatory markers such as C-reactive protein in response
to exercise (10). A recent study in exercised rats also revealed
enhanced cardiac ﬁbrosis and an increased arrhythmia
inducibility (11).
In addition to structural remodeling, alteration in the
activity of the autonomic nervous system may potentially
contribute to AF in athletes. One study in dogs infused
with catecholamines and/or acetylcholine suggests that
cholinergic or vagal stimulation is mainly responsible for
spontaneous AF initiation whereas adrenergic stimulation
modulates the initiation as well as the maintenance of AF
(12). This ﬁnding is supported by an older study, in which
vagal stimulation induced AF in dogs (13). This study also
showed that vagal stimulation necessary re-entry circuits
by shortening the atrial refractory period (13). In humans,
the GIRAFA (Grup Integrat de Recerca en Fibril-lació
Auricular) study found that vagal AF, or AF activated by the
parasympathetic nervous system, is the main form of lone
AF; this study, however, was not conducted in athletes (14).
Swanson (9) offered the provocative hypothesis that esoph-
ageal acid reﬂux caused by exercise could stimulate the vagal
nerves (due to the proximity to the esophagus), thus leading
to AF in athletes. Finally, two other more extrinsic mecha-
nisms have been suggested to either induce or contribute to
AF in athletes. First, if inappropriately hydrated, athletes
may suffer from dehydration or hypovolemia, both of which
have been proposed in a case series to cause AF (15).
However, all patients in that particular patient cohort were
critically ill, which questions the validity of these ﬁndings to
all athlete subgroups. Second, several illicit drugs or
substances banned by the World Anti-Doping Agency may
cause cardiac arrhythmias, including AF in athletes (16).
These drugs include anabolic steroids, erythropoiesis-
stimulating agents, growth hormone, and stimulants (2).
However, more studies are needed to elucidate the molecular
pathways responsible for AF induction and maintenance in
these cases.
In this issue of the Journal, Guasch et al. (17) have gone
a step further to establish and characterize a novel animal
model of endurance exercise. The authors focused on
exploring the mechanisms underlying AF development related
to chronic endurance training. Based on previous studies
(11), the authors subjected rats to daily 1-hour treadmill
training for 8 or 16 weeks, which mimicked chronic
endurance exercise in athletes. Based on maximum oxygen
uptake, the authors suggested that the 16-week treadmill-
training regimen in rats corresponds roughly to about
10 years of exercise training in humans. Next, the authors
demonstrated that the rats subjected to chronic exercise were
more susceptible to pacing-induced AF. Furthermore, the
increase in AF susceptibility was associated with an enhanced
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79vagal tone, atrial dilation, and increased ﬁbrosis, similar to
ﬁndings in humans with long-term endurance training (18).
In addition, the authors showed that the cessation of exercise
reversed AF inducibility in these animals, suggesting a cause-
and-effect relationship between endurance exercise and AF
promotion. However, this deconditioning protocol failed
to attenuate atrial dilation and ﬁbrosis, suggesting that
molecular pathways other than structural remodeling also
contribute to the AF arrhythmogenesis in athletes. Consis-
tent with this notion, the authors demonstrated that an
enhanced baroreﬂex and sensitivity to cholinergic stimulation
of the acetylcholine-dependent potassium current (IKACh)
play central roles in this exercise model. Furthermore,
molecular studies suggested that altered messenger ribonu-
cleic acid expression levels of several regulators of G-protein–
signaling (RGS) proteins may contribute to the augmentation
of IKACh sensitivity to vagal tone. To further support this
notion, the authors used a mouse model that lacks the RGS4
protein, mimicking the situation in the animal model, and
demonstrated that RGS4 deﬁciency predisposes to pacing-
induced AF.
This work by Guasch et al. (17) is the ﬁrst study to date
that provides mechanistic insights into the pathogenesis
underlying AF caused by chronic vigorous exercise. Their
ﬁndings suggest that enhanced vagal activity plays an
important role, through an augmented baroreﬂex respon-
siveness and increased sensitivity to cholinergic stimulation at
the level of the atrial cardiomyocytes. As with every excellent
innovative study, the current work raises several important
questions. First, optical mapping experiments are needed in
both animal models and in patients to determine the exact
arrhythmic mechanism in response to endurance training.
Second, it remains to be established whether other modes of
high-intensity endurance training such as swimming and
voluntary wheel-running involve similar pathogenic mecha-
nisms associated with AF promotion. Third, other studies
have suggested that endurance training could also modify
intracellular calcium handling (19,20). A number of studies
from Dr. Wisloff’s group demonstrated that exercise training
enhanced calcium cycling, through increasing the activity
of calcium/calmodulin-dependent kinase IId (CaMKIId)
(19,20). CaMKIId activity was also found to be enhanced in
patients with AF (21) and associated with AF promotion
through phosphorylation of its downstream targets, ryano-
dine receptor type 2 channels and phospholamban (22). We
have demonstrated that the augmented CaMKII-mediated
phosphorylation of ryanodine receptor type 2 channels
promotes AF initiation by amplifying calcium release from
the sarcoplasmic reticulum and ultimately increasing trig-
gered activity by activation of the sodium/calcium exchanger
(22). Therefore, it is intriguing to explore the possible
mechanism of exercise-induced calcium remodeling associ-
ated with AF pathogenesis. Finally, although detraining
might be beneﬁcial in athletes, it remains to be determined
which aspects of detraining are most beneﬁcial in terms of
reducing the risk of cardiac arrhythmias.It seems reasonable to propose IKACh blockers as a
promising approach to AF prevention in athletes prone to
this condition, given that selective IKACh blockers are
currently being developed for the treatment of AF because of
their atrial-speciﬁc channel inhibition (23). Because atrial
myocytes from athletes have a higher IKACh sensitivity,
selective IKACh blockers might be less likely to reduce the
already lower heart rates in athletes compared with similar
drug classes such as muscarinic acetylcholine receptor
antagonists. Guasch et al. (17) opens up new research
avenues for both clinical and basic scientists to better
understand the development and potential treatment of
arrhythmias in athletes.Reprint requests and correspondence: Dr. Xander H. T.
Wehrens, Baylor College of Medicine, Molecular Physiology and
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